Online Education | Pediatric Drug Therapy 2018 | Drug Eruptions in the Pediatric Population

Is it a Drug Eruption? A Viral Exanthem? Graft vs. Host Disease? Yes!

Robert Sidbury, MD, MPH   
Professor, Dept. of Pediatrics,
University of Washington School of Medicine;
Chief, Division of Dermatology,
Seattle Children's Hospital, Seattle, WA

Back to the activity set home.

Objectives for Learning Outcomes

At the conclusion of this activity, participants will be able to:

  1. Review the differential diagnosis of fever and rash in kids. Discriminate benign from not benign.
  2. Contrast "urticaria multiforme" and erythema multiforme.
  3. Discuss life-threatening medication reactions.
  4. Highlight how medication reactions can be in the differential of child abuse.
 

Completion Requirements

  • Watch or listen to the presentation.
  • Submit an evaluation.
  • Complete coursework by the expiration date (We'll remind you 60 days out.)

Disclosures

What is this?

Robert Sidbury, MD, MPH

  • Grant/Research Support: Site Investigator for Regeneron (Dupilumab for AD), Scioderm (Zublisa for EB)
  • Advisory Committees or Review Panels: Advisory Board x1 for Pfizer regarding Crisaboroic for AD 
Course summary
Maximum credit available: 
  • 1.00 Contact hours
  • 1.00 Pharmacology hours at the advanced practice level
Available: 
06/10/2018
Expires: 
06/10/2021
Cost:
$20.00

Available Credit

  • 1.00 Contact hours
  • 1.00 Pharmacology hours at the advanced practice level

Activity Availability

Available: 
06/10/2018
Expires: 
06/10/2021

Price

Cost:
$20.00
Please login or create account to take this course.